logo
Plus   Neg
Share
Email

CTI BioPharma Corp. Q1 adjusted earnings of -$ per share

Below are the earnings highlights for CTI BioPharma Corp. (CTIC):

-Earnings: -$4.10 million in Q1 vs. -$19.83 million in the same period last year.
-EPS: -$0.08 in Q1 vs. -$0.71 in the same period last year.
-Revenue: $10.48 million in Q1 vs. $0.75 million in the same period last year.

For comments and feedback contact: editorial@rttnews.com

Follow RTT